Suchergebnisse - "Talamonti, Marina"

PubPharm (22)

1

Tildrakizumab : the value of a personalized and flexible approach for treating moderate-to-severe plaque psoriasis in patients with high body weight or high disease burden

enthalten in: Expert opinion on biological therapy | 2024

von Dapavo, P. | Burlando, M. | Guarneri, C. | +4

2

Deucravacitinib, a selective tyrosine kinase 2 inhibitor, for the treatment of moderate-to-severe plaque psoriasis

enthalten in: Expert opinion on pharmacotherapy | 2023

von Galluzzo, M. | Vellucci, L. | Marcelli, L. | +3

3

Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis : Post-Hoc Analysis of the SUPREME Study

enthalten in: Clinical, cosmetic and investigational dermatology | 2023

von Talamonti, M. | Russo, F. | Malara, G. | +23

4

Allelic Variants of HLA-C Upstream Region, PSORS1C3, MICA, TNFA and Genes Involved in Epidermal Homeostasis and Barrier Function Influence the Clinical Response to Anti-IL-12/IL-23 Treatment of Patients with Psoriasis

enthalten in: Vaccines | 2022

von Morelli, M. | Galluzzo, M. | Scarponi, C. | +6

5

Tildrakizumab in moderate-to-severe plaque psoriasis : A multicenter, retrospective, real-life study

enthalten in: Dermatologic therapy | 2022

von Caldarola, G. | Galluzzo, M. | Bernardini, N. | +12

6

Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas : Scalp, Nail, Palmoplantar and Genital Psoriasis

enthalten in: Journal of clinical medicine | 2022

von Galluzzo, M. | Talamonti, M. | Cioni, A. | +5

7

Secukinumab for the treatment of palmoplantar psoriasis : a 2-year, multicenter, real-life observational study

enthalten in: Expert opinion on biological therapy | 2022

von Galluzzo, M. | Talamonti, M. | Atzori, L. | +12

8

Safety of COVID-19 vaccines in patients with psoriasis undergoing therapy with anti-interleukin agents

enthalten in: Expert opinion on biological therapy | 2021

von Talamonti, M. | Galluzzo, M.

9

Prevalence of HPV genital infection in patients with moderate-to-severe psoriasis undergoing systemic treatment with immunosuppressive agents or biologics

enthalten in: European journal of dermatology : EJD | 2021

von Offidani, A. | Radi, G. | Bianchi, L. | +6

10

Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis : A Post hoc Analysis of the SUPREME Study

enthalten in: Acta dermato-venereologica | 2021

von Talamonti, M. | Malara, G. | Natalini, Y. | +22